首页> 外文期刊>The Canadian journal of cardiology >Determinants and Prognostic Implications of Left-Heart Filling Pressures in Tetralogy of Fallot
【24h】

Determinants and Prognostic Implications of Left-Heart Filling Pressures in Tetralogy of Fallot

机译:Determinants and Prognostic Implications of Left-Heart Filling Pressures in Tetralogy of Fallot

获取原文
获取原文并翻译 | 示例
           

摘要

abstract_textpBackground: Elevated pulmonary artery wedge pressure (PAWP) is the hallmark of left-heart failure and is responsible for heart failure symptoms and mortality. Although PAWP typically correlates with right atrial pressure (RAP), it is primarily dependent on left-heart myocardial properties and volume status. As right-heart disease can occur in the absence of left-heart disease in patients with tetralogy of Fallot (TOF), we hypothesized that RAP was the primary determinant of PAWP in this population./ppMethods: A cohort study of adults with TOF that underwent right-heart catheterization at Mayo Clinic Rochester (1990 to 2017) to determine the relationship among RAP, PAWP, and mortality./ppResults: Among 213 patients (male 105; age 37 +/- 14 years), the mean PAWP was 14 +/- 5 mm Hg, and RAP was 11 +/- 5 mm Hg. RAP was the strongest predictor of PAWP (0 = 0.68, standard error = 0.06, P 0.001), independent of left-heart disease and atherosclerotic cardiovascular risk factors. The patients with high PAWP also had normal tissue Doppler velocities, suggesting normal left-ventricular myocardial properties. PAWP was an independent predictor of death/transplant (hazard ration [HR] 1.11, 95% confidence interval [CI], 1.03-1.20, P = 0.004). However, when RAP was incorporated into the regression model, RAP (and not PAWP) became the independent predictor of outcomes (HR 1.14, 95% CI, 1.06-1.22, P = 0.001)./ppConclusions: The current study showed that RAP was the primary determinant of PAWP and accounts, to some extent, for the mortality in patients with TOF and high PAWP. The data provide new insight in the pathophysiology of disease progression for symptomatic patients with TOF./p/abstract_text

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号